Slide 11 BY: MR. SUMAN JYOTI KHAITAN MANAGING PARTNER KHAITAN & PARTNERS ADVOCATES & NOTARIES W-13, WEST WING GREATER KAILASH PART-II NEW DELHI-110048, INDIA PH.:…

Slide 1Pharmaceutical Policy Reform in Korea Tae-Jin Lee, PhD. Seoul National University, Korea Slide 2 Outline Korean Health Care System Policy background New pharmaceutical…

Slide 1March 16, 2010 Research!America Annual Meeting of Members Slide 2 Agenda I.Call to Order Georges Benjamin, MD, Secretary, Board of Directors II.Presidents Report Mary…

Slide 1Regulatory harmonization, a regulatory perspective Hubert Leufkens, Medicines Evaluation Board/Utrecht University Slide 2 College ter Beoordeling van Geneesmiddelen…

1. Chronic care in Spain 1 Joan Escarrabill MD Chronic Care Program– Barcelona Esquerra. Hospital Clínic (Barcelona) Master Plan for Respiratory Diseases (PDMAR) &…

1. Rational use of drugs: an overview Kathleen Holloway Technical Briefing Seminar November 2009 Department of Essential Medicines and Pharmaceutical Policy TBS 2009 2. Department…

Slide 1Defining Non-Medical Use of Prescription Opioids within Health Care Claims: A Systematic Review Gerald Cochran, PhD 1,2 Bongki Woo, MSW 3 Wei-Hsuan Lo-Ciganic, PhD,…

Slide 11 Management Sciences for Health: 40 Years of Strengthening Health Systems for Greater Health Impact Stronger health systems. Greater health impact. Access to Medicines…

Slide 1 MOSCOW PHARMACEUTICAL SOCIETY MOSCOW PHARMACEUTICAL SOCIETY REGIONAL NONCOMMERCIAL ORGANIZATION MPhS ANNUAL REPORT 2014 Slide 2 FIP PROUD MEMBER We are pleased to…

Slide 1 Medicines Need and Access: Are there Gender Inequities? Anita Wagner Paul Ashigbie João Carapinha Aakanksha Pande Dennis Ross-Degnan Peter Stephens Saul Walker Catherine…